Increasing visual field testing frequency enables early glaucoma detection

Article

Increasing visual field testing frequency can lead to the earlier detection of glaucoma.

Increasing visual field testing frequency can lead to the earlier detection of glaucoma, according to a study in the Archives of Ophthalmology.

Dr Kouros Nouri-Mahdavi et al., Glaucoma Division, Jules Stein Eye Institute. University of California, Los Angeles, California, USA, assessed the visual fields of 468 eyes of 381 patients from the Advanced Glaucoma Intervention Study. Patients had 10 or more reliable visual fields and 3 or more follow-up years.

A low-frequency data group was created for every other visual field examination and the original group was maintained as the high-frequency group. A global and point-wise linear regression criterion was used to compare proportion of progressing eyes and time to progression between the two groups.

For the high-frequency data group there was a median of 20 visual field examinations. In the low-frequency data group there was a median number of 12 visual field examinations. There were 204 eyes in the high-frequency data group and 160 in the low-frequency group.

The high-frequency group was more likely to detect glaucoma progression earlier on than the low-frequency group. Point-wise linear regression criteria was more likely to detect improvement in the high-frequency data set.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.